Concepedia

Mark Cameron

MC

14

Publications

554

Citations

14

H-Index

1956

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Mark Cameron is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, biochemistry, and pharmacology.

Top concepts

MedicineBiochemistryPharmacologyNatural SciencesDrug DiscoveryMedicinal ChemistryOrganic ChemistryBiologyBioorganic ChemistryChemistry

Publications per year

1956–2013

14

Publications

14

Simplified Aldehyde-Fuchsin Staining of Neurosecretory Cells

Mark Cameron, Janice Steele · Stain Technology · 1959 · 163 citations

Original Aldehyde-fuchsin Method, Aldehyde-fuchsin Staining, Engineering +15

A Convenient Method for the Preparation of 5-, 6- and 7-Azaindoles and Their Derivatives

David Hands, Brian Bishop, Mark Cameron et al. · Synthesis · 1996 · 71 citations

Combinatorial Chemistry, Derivative (Chemistry), Derivatives +10

The Expedient Synthesis of 4,2‘-Difluoro-5‘-(7-trifluoromethyl- imidazo[1,2<i>-a</i>]pyrimidin-3-yl)biphenyl-2-carbonitrile, a GABA α2/3 Agonist

Mark Cameron, Bruce S. Foster, Joseph E. Lynch et al. · Organic Process Research & Development · 2006 · 45 citations

SOME DETAILS OF ULTRASTRUCTURE IN THE DEVELOPMENT OF FLAGELLAR FIBERS OF THE TENEBRIO SPERM

Mark Cameron · Canadian Journal of Zoology · 1965 · 38 citations

Tenebrio Sperm, Microscopy, Accessory Fibers +17

A Practical Synthesis of Renin Inhibitor MK-1597 (ACT-178882) via Catalytic Enantioselective Hydrogenation and Epimerization of Piperidine Intermediate

Carmela Molinaro, Scott Shultz, Amélie Roy et al. · The Journal of Organic Chemistry · 2011 · 34 citations

Hypertension, Bioorganic Chemistry, Chemistry +19

Rows per page

1–5 of 14